Tissue engineering for bone regeneration: stem cells and growth factors in biomaterial scaffolds

被引:0
作者
Honsawek, Sittisak [1 ]
Parkpian, Vinai [2 ]
机构
[1] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand
[2] Chulalongkorn Univ, Fac Med, Dept Orthopaed, Bangkok 10330, Thailand
关键词
bone regeneration; growth factors; scaffolds; stem cells; tissue engineering;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Bone tissue engineering requires a scaffold conducive to cell attachment and maintenance of cell function, together with a rich source of osteoprogenitor cells in combination with osteoinductive growth factors. Bone loss as a result of trauma or disease is an increasingly serious health problem. The requirement for new bone to replace or restore the function of injured, damaged, or lost bone is a major clinical and socioeconomic need. Bone defects still represent a major challenge for orthopaedic and reconstructive surgeons. Objective: This review aims at outlining the role of stem cells and growth factors in scaffolds, focusing on the use of mesenchymal stem cells and bone morphogenetic proteins as applied to the research and practice of bone tissue engineering. Results and conclusion: Bone tissue engineering has been emerging as a valid approach to the current therapies for bone regeneration. Therefore, tissue engineering offers a number of possible strategies to the generation of living prosthesis that could integrate with host tissue reducing the need for further surgery or possible implant failure.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 80 条
  • [1] [Anonymous], 2002, NEUROSURG FOCUS, DOI DOI 10.3171/FOC.2002.13.6.3
  • [2] Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products
    Bae, HW
    Zhao, L
    Kanim, LEA
    Wong, P
    Delamarter, RB
    Dawson, EG
    [J]. SPINE, 2006, 31 (12) : 1299 - 1306
  • [3] Bone induction by Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2
    Bessho, K
    Konishi, Y
    Kaihara, S
    Fujimura, K
    Okubo, Y
    Iizuka, T
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2000, 38 (06) : 645 - 649
  • [4] The use of rhBMP-2 in interbody fusion cages - Definitive evidence of osteoinduction in humans: A preliminary report
    Boden, SD
    Zdeblick, TA
    Sandhu, HS
    Heim, SE
    [J]. SPINE, 2000, 25 (03) : 376 - 381
  • [5] 1998 Volvo Award winner in basic science studies - Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1)
    Boden, SD
    Titus, L
    Hair, G
    Liu, YS
    Viggeswarapu, M
    Nanes, MS
    Baranowski, C
    [J]. SPINE, 1998, 23 (23) : 2486 - 2492
  • [6] Biology of lumbar spine fusion and use of bone graft substitutes: Present, future, and next generation
    Boden, SD
    [J]. TISSUE ENGINEERING, 2000, 6 (04): : 383 - 399
  • [7] Boden SD, 2000, CLIN ORTHOP RELAT R, pS225
  • [8] Boden SD, 1999, CLIN ORTHOP RELAT R, pS84
  • [9] BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
  • [10] IMMUNOLOCALIZATION AND EXPRESSION OF BONE MORPHOGENETIC PROTEIN-2 AND PROTEIN-4 IN FRACTURE-HEALING
    BOSTROM, MPG
    LANE, JM
    BERBERIAN, WS
    MISSRI, AAE
    TOMIN, E
    WEILAND, A
    DOTY, SB
    GLASER, D
    ROSEN, VM
    [J]. JOURNAL OF ORTHOPAEDIC RESEARCH, 1995, 13 (03) : 357 - 367